Replicate Design [Two-Stage / GS Designs]

posted by Naveen Kumar – India, 2014-06-23 15:19 (4377 d 07:47 ago) – Posting: # 13124
Views: 7,836

Dear All,

Please suggest, can we design full replicate bioequivalence study (molecule is highly variable) in stages for EMEA submission.

My concern is Power will play pivotal role in stage design, which not be in replicate (full) designs.

Regards,
Naveen Kumar.SR


Edit: Category and subject line changed. [Helmut]

Complete thread:

UA Flag
Activity
 Admin contact
23,654 posts in 4,992 threads, 1,571 registered users;
158 visitors (0 registered, 158 guests [including 13 identified bots]).
Forum time: 23:07 CEST (Europe/Vienna)

Scientists often have a naïve faith that
if only they could discover enough facts about a problem,
these facts would somehow arrange themselves
in a compelling and true solution.    Theodosius Dobzhansky

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5